ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Wearable Injector Devices Market Report to 2029 - by Application, Product and Region - ResearchAndMarkets.com

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 3, 2023 GMT

DUBLIN--(BUSINESS WIRE)--Jan 3, 2023--

The “Wearable Injector Devices Market Report by Application, by Product, and by Region - Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The wearable injector devices market size is estimated to be USD 5,213.4 million in 2021 and is expected to witness a CAGR of 15.75% during the forecast period 2022-2029.

The increased prevalence of chronic diseases like cancer, cardiovascular disease, and diabetes and growing number of difficult-to-transport biologics in the pipeline for new medications are projected to drive the market growth in near future. However, demand for alternate drug delivery methods and increased costs are expected to restrain the market growth.

Companies Mentioned

  • Sorrel Medical (Israel)
  • Enable Injections (Ohio)
  • Medtronic Plc (Ireland)
  • Insulet Corporation (US)
  • United Therapeutics Corp (Us)
  • CeQur SA (Switzerland)
  • Sensile Medical (Switzerland)
  • ATS Automation (Canada)
  • West Pharmaceutical Services Inc (US)
  • Amgen (California)
  • Valeritas (US)
  • Sonceboz (Switzerland)
  • Noble (US)
  • Elcam Drug Delivery Device (Israel)
  • Ypsomed (Switzerland)
  • Bespak (UK)
  • Tandem Diabetes Care (US)
  • Stevanato Group (Italy)
  • Subcuject (Denmark)
  • Weibel CDS AG (Switzerland)
  • Neuma (US)

ADVERTISEMENT

Market Segmentation:

By Application (Revenue, USD Million)

  • Diabetes
  • Oncology
  • Autoimmune Disorder
  • Cardiovascular Diseases
  • Others

Product (Revenue, USD Million)

  • Reusable
  • Disposable

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/pelya8

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005427/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2023.

PUB: 01/03/2023 07:36 AM/DISC: 01/03/2023 07:35 AM

http://www.businesswire.com/news/home/20230103005427/en